رجوع
35
نطاق اليوم
KWD 11.77
KWD 12.21
نطاق 52 أسبوعًا
KWD 11.61
KWD 24.60
حجم التداول
1,231,564
متوسط 50 يوم / 200 يوم
KWD 14.62
/
KWD 18.97
الإغلاق السابق
KWD 11.80
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -19.9 | 0.4 |
| P/B | 0.9 | 2.9 |
| ROE % | -4.5 | 3.8 |
| Net Margin % | -2.4 | 3.9 |
| Rev Growth 5Y % | 10.4 | 10.0 |
| D/E | 2.4 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 18.850
+57.3%
Low: KWD 16.250
High: KWD 21.000
مكرر الربحية المستقبلي
28.3
ربحية السهم المستقبلية
KWD 0.423
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
3.4 B
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2029 |
KWD 0.850
KWD 0.824 – KWD 0.900
|
4.5 B | 1 |
| FY2028 |
KWD 0.588
KWD 0.570 – KWD 0.622
|
4.1 B | 1 |
| FY2027 |
KWD 0.489
KWD 0.171 – KWD 0.905
|
3.6 B | 6 |
النقاط الرئيسية
Revenue grew 10.43% annually over 5 years — strong growth
Debt/Equity of 2.35 — high leverage
Generating 195.60M in free cash flow
PEG of 0.47 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 4.19%
Capital efficient — spends only 2.38% of revenue on capex
النمو
Revenue Growth (5Y)
10.43%
Revenue (1Y)6.24%
Earnings (1Y)N/A
FCF Growth (3Y)-2.32%
الجودة
Return on Equity
-4.45%
ROIC5.09%
Net Margin-2.35%
Op. Margin11.77%
الأمان
Debt / Equity
2.35
Current Ratio1.87
Interest Coverage1.43
التقييم
P/E Ratio
-19.90
P/B Ratio0.91
EV/EBITDA13.70
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6.24% | Revenue Growth (3Y) | 9.82% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 10.43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.31B | Net Income (TTM) | -77.90M |
| ROE | -4.45% | ROA | -0.95% |
| Gross Margin | 23.12% | Operating Margin | 11.77% |
| Net Margin | -2.35% | Free Cash Flow (TTM) | 195.60M |
| ROIC | 5.09% | FCF Growth (3Y) | -2.32% |
| Safety | |||
| Debt / Equity | 2.35 | Current Ratio | 1.87 |
| Interest Coverage | 1.43 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -19.90 | P/B Ratio | 0.91 |
| P/S Ratio | 0.47 | PEG Ratio | 0.47 |
| EV/EBITDA | 13.70 | Dividend Yield | 0.00% |
| Market Cap | 1.55B | Enterprise Value | 5.34B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.31B | 3.11B | 2.74B | 2.54B | 2.23B |
| Net Income | -77.90M | -168.10M | -11.90M | -54.60M | -70.90M |
| EPS (Diluted) | -0.61 | -1.33 | -0.09 | -0.59 | -1.12 |
| Gross Profit | 765.00M | 745.60M | 647.50M | 574.90M | 491.40M |
| Operating Income | 389.50M | 348.80M | 328.00M | 345.20M | 302.20M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.24B | 7.89B | 6.88B | 6.68B | 6.12B |
| Total Liabilities | 4.72B | 4.25B | 3.51B | 3.40B | 3.82B |
| Shareholders' Equity | 1.71B | 1.79B | 1.99B | 2.00B | 1.09B |
| Total Debt | 4.02B | 3.70B | 3.06B | 2.93B | 3.29B |
| Cash & Equivalents | 239.90M | 269.50M | 195.90M | 282.90M | 389.90M |
| Current Assets | 1.15B | 1.12B | 895.00M | 921.00M | 946.10M |
| Current Liabilities | 615.50M | 624.40M | 523.00M | 493.40M | 536.80M |
درجات الاستراتيجيات
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#310 of 616
النشاط الأخير
دخل
Price/Sales Ratio Focus (Ken Fisher)
Mar 24, 2026